The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men
Abstract
Background The intercellular adhesion molecule ICAM-1 mediates adhesion and transmigration of leucocytes to the vascular endothelial wall, a step proposed to be critical in the initiation and progression of atherosclerosis. Whether concentrations of soluble ICAM-1 (sICAM-1) are raised in apparently healthy individuals who later suffer acute myocardial infarction is unknown.Methods We obtained baseline plasma samples from a prospective cohort of 14,916 healthy men enrolled in the Physicians' Health Study. With a nested case-control design, we measured sICAM-1 concentrations for 474 participants who developed a first myocardial infarction, and 474 controls (participants who remained healthy throughout the 9-year follow-up). Cases were matched to controls according to age and smoking status at the time of myocardial infarction.Findings We found a significant association between increasing concentration of sICAM-1 and risk of future myocardial infarction (p = 0.003), especially among participants with baseline sICAM-1 concentrations in the highest quartile (> 260 ng/mL; relative risk 1.6 [95% Cl 1.1-2.4], p = 0.02). This association was present overall as well as among non-smokers, and persisted after control for lipid and non-lipid risk factors. In multivariate analyses, the risk of future myocardial infarction was 80% higher for participants with baseline sICAM-1 concentrations in the highest quartile (relative risk 1.8 [1.1-2.8], p = 0.02). Similar risk estimates were seen among non-smokers. We found slight but significant correlations between sICAM-1 and fibrinogen, high-density-lipoprotein cholesterol, homocysteine, triglycerides, tissue-type plasminogen-activator antigen, and C-relative protein, but adjustment for these altered the risk little. The risk of myocardial infarction associated with raised concentrations of sICAM-1 seemed to increase with length of follow-up.Interpretation Our data support the hypothesis that cellular mediators of inflammation have a role in atherogenesis and provide a clinical basis to consider antiadhesion therapies as a novel means of cardiovascular disease prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“sICAM-1 has been shown to be associated with increased risk of future nonfatal cardiovascular events and incident diabetes. 37,38”
From Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide (2026) · cites this paper as [37]
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
Adhesion receptors of the immune system
Springer, T. A. (1990) · Nature · doi:10.1038/346425a0 · Cited by 6,477
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Dustin, M. L., Rothlein, R., Bhan, A. K., Dinarello, C. A., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.1.245 · Cited by 2,450
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
Molecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,029
Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis
Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,710
Pober, J. S., Gimbrone, M. A., Lapierre, L. A., Mendrick, D. L., Fiers, W., Rothlein, R., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.6.1893 · Cited by 1,413
Davies, M. J., Gordon, J. L., Gearing, A. J. H., Pigott, R., Woolf, N., Katz, D. R., & Kyriakopoulos, A. (1993) · The Journal of Pathology · doi:10.1002/path.1711710311 · Cited by 777
Pigott, R., Dillon, L. P., Hemingway, I., & Gearing, A. J. H. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91234-h · Cited by 650
Cited by
Sorted by citations
Items 801–900 of 999
Doo, Y., Han, S. J., Park, W., Kim, S., Choi, S., Cho, G., Hong, K.-S., Han, K., Lee, N., Oh, D., et al. (2005) · Clinical Cardiology · doi:10.1002/clc.4960280112 · Cited by 16
Soluble adhesion molecules in ischaemic heart disease
Malik, I. S. (1999) · European Heart Journal · doi:10.1053/euhj.1999.1576 · Cited by 16
Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration
Evans, J. R., & Henshaw, K. S. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000253 · Cited by 16
BAJAJ, H. S., Ye, C., Hanley, A. J., Sermer, M., Zinman, B., & Retnakaran, R. R. (2018) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118779924 · Cited by 15
Meredith, I. T., Plunkett, J. C., Worthley, S. G., Hope, S. A., & Cameron, J. D. (2005) · Coronary Artery Disease · doi:10.1097/00019501-200510000-00001 · Cited by 15
Bielinski, S. J., Pankow, J. S., Foster, C. L., Miller, M. B., Hopkins, P. N., Eckfeldt, J. H., Hixson, J., Liu, Y., Register, T., Myers, R. H., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.10.006 · Cited by 15
Lin, C., Chen, M.-F., Lin, L., Liau, C., Lee, Y., & Su, T. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.0696 · Cited by 15
“Many studies have shown that inflammatory and/or fibrinolytic markers were closely related to CV morbidity and mortality (6-9).”
BackgroundCirculating Adhesion Molecules in Patients with Internal Carotid Artery Stenosis
Okulla, T., Gass, S., Böhme, K., Tiemann, K., Harbrecht, U., Klockgether, T., & Pohl, C. (2002) · Cerebrovascular Diseases · doi:10.1159/000063717 · Cited by 15
Lazaridou, A., Papoutsi, Z., Βiliaderis, C. G., & Moutsatsou, P. (2010) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2010.11.019 · Cited by 15
Hillis, G. S., Terregino, C. A., Taggart, P., Killian, A. J., Zhao, N., Kaplan, J. B., Dalsey, W. C., & Mangione, A. (2001) · Annals of Emergency Medicine · doi:10.1067/mem.2001.117199 · Cited by 15
Eschen, O., Christensen, J. H., Dethlefsen, C., & Schmidt, E. B. (2008) · Biomarker Insights · doi:10.1177/117727190800300002 · Cited by 15
“This also fits the findings that both sCAMs (Blankenberg, Barbaux and Tiret, 2003; Ridker et al. 1998; Ridker, Buring and Rifai, 2001) and FMD (Gokce, Keaney, Jr.”
ResultAnticoagulation factors as predictors of transplant-associated coronary artery disease
Labarrere, C. A. (2000) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(00)00112-1 · Cited by 15
New Clinical Markers Predictive of Cardiovascular Disease: The Role of Inflammatory Mediators
Rackley, C. E. (2004) · Cardiology in Review · doi:10.1097/01.crd.0000126083.86717.5b · Cited by 14
“Cell adhesion molecules are expressed on endothelial cells and may in part mediate adhesion of circulating leukocytes to the vascular endothelium, possibly initiating atherosclerosis.(11) Cell adhesion molecules are also expressed in several components of atherosclerotic plaque, and evidence suggests a role for these…”
BackgroundInfluentialStat3β mitigates development of atherosclerosis in apolipoprotein E-deficient mice
Lee, J., Baldwin, W. M., Lee, C., & Desiderio, S. V. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1013-5 · Cited by 14
“Such markers include IL-6 [2], C-reactive protein [3–5], sICAM1 [6], and CD40L [7].”
Trindade, F., Perpétuo, L., Ferreira, R. M., Leite-Moreira, A. F., Falcão‐Pires, I., Guedes, S. D. M., & Vitorino, R. M. P. (2021) · Biomarkers · doi:10.1080/1354750x.2021.1904002 · Cited by 14
Arıbaş, A., Kayrak, M., Tekinalp, M., Akıllı, H., Alibaşiç, H., Yıldırım, S., Gunduz, M., Taner, A., & Ünlü, A. (2015) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.30.3.316 · Cited by 14
“[9].”
Laboratory medicine for molecular imaging of atherosclerosis
Mangge, H., Almer, G., Stelzer, I., Reininghaus, E. Z., & Prassl, R. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.06.029 · Cited by 15
Inflamación e infección en la enfermedad coronaria estable y en el síndrome coronario agudo
García, J. B., Martínez, P. M., Rodríguez, J. F. M., Carpente, M. M. D. L. T., Bustamante, R. B., Peral, A. B. G., de Lejarazu, R. O., Bouza, J. M. E., García, S. B., & y, F. F.-A. (2001) · Revista Española de Cardiología · doi:10.1016/s0300-8932(01)76333-6 · Cited by 14
Poloxamer 407 increases soluble adhesion molecules, ICAM-1, VCAM-1 and E-selectin, in C57BL/6 mice
Johnston, T. P. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.12.0014 · Cited by 14
“With regard to sCAMs and atheroclerosis, it has been suggested that sICAM-1 is more predictive of future coronary artery disease,([23,47]) whereas sVCAM-1 is more predictive of existing atherosclerosis.”
BackgroundVlachopoulos, C. V., Xaplanteris, P., Sambatakou, H., Mariolis, E., Bratsas, A., Christoforatou, E., Miliou, A., Aznaouridis, K. A., & Stefanadis, C. (2011) · HIV Medicine · doi:10.1111/j.1468-1293.2011.00935.x · Cited by 14
Hulok, A., Ściborski, K., Marczak, J., Bańkowski, T., Poręba, R., & Negrusz‐Kawecka, M. (2014) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/37232 · Cited by 14
Empana, J. P., Sykes, D. H., & Juhan-Vague, I. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.08.202 · Cited by 14
Jackson, E. W., Wise, M., Bonman, J. M., Obert, D. E., Hu, G., & Peterson, D. M. (2008) · Crop Science · doi:10.2135/cropsci2007.11.0658 · Cited by 14
“In addition, Theriault et al. (2002) showed that α-tocotrienol reduced endothelial leukocyte adhesion molecule expression and monocytic cell adherence, both of which have been associated with atherosclerosis and risks of myocardial infarction in humans (Peter et al., 1997; Ridker et al., 1998).”
BackgroundOkapcová, J., & Gábor, D. (2004) · Angiology · doi:10.1177/00033197040550i604 · Cited by 14
Clausell, N., Prado, K. F., & Ribeiro, J. P. (1999) · International Journal of Cardiology · doi:10.1016/s0167-5273(98)00370-2 · Cited by 14
Impact of rHuEPO therapy initiation on soluble adhesion molecule levels in haemodialysis patients
Kahraman, S., Yılmaz, R., Kırkpantur, A., Gençtoy, G., Arıcı, M., Altun, B., Erdem, Y., Yasavul, Ü., & Turgan, Ç. (2005) · Nephrology · doi:10.1111/j.1440-1797.2005.00405.x · Cited by 14
Souter, I. C., Janzen, C., Martı́nez-Maza, O., Breen, E. C., Stanczyk, F. Z., Chaudhuri, G., & Nathan, L. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.048 · Cited by 14
Becker, S., Schomburg, L., Renko, K., Tölle, M., van der Giet, M., & Tietge, U. J. F. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.105 · Cited by 15
Eschen, O., Christensen, J. H., Dethlefsen, C., & Schmidt, E. B. (2008) · Europe PMC (PubMed Central) · Cited by 14
Kagan, J. (2002) · Disease Markers · doi:10.1155/1998/698239 · Cited by 1
Markov, M., Georgiev, T., Angelov, A. K., & Dimova, M. (2024) · Rheumatology International · doi:10.1007/s00296-024-05693-3 · Cited by 13
Teichert, T., Vossoughi, M., Vierkötter, A., Sugiri, D., Schikowski, T., Hoffmann, B. H., Schulte, T., Roden, M., Raulf, M., Luckhaus, C., et al. (2014) · Environmental Research · doi:10.1016/j.envres.2014.06.021 · Cited by 13
Progestogens and target tissues: Vascular systems
Mueck, A. O., & Seeger, H. (2009) · Maturitas · doi:10.1016/j.maturitas.2008.12.003 · Cited by 13
Fowler, J., Tsui, M. T., Chavez, J., Khan, S., Ahmed, H., Smith, L. M., & Jia, Z. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211033812 · Cited by 14
“Further, increases in IL-6 and ICAM-1 concentration in apparently healthy men have been linked with an increased incidence of repeat myocardial infarctions.(28,29) Finally, studies conducted on human arterial atherosclerotic walls have found a marked increase in concentrations of both IL-6 and IL-8.”
BackgroundA Clinical Perspective on Arsenic Exposure and Development of Atherosclerotic Cardiovascular Disease
Kaur, G., Desai, K. P., Chang, I. Y., Newman, J. D., Mathew, R. O., Bangalore, S., Venditti, F. J., & Sidhu, M. S. (2022) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07313-9 · Cited by 13
“Markers of chronic inflammation linked to high-dose iAs exposure include endothelial adhesion molecules, particularly soluble intercellular adhesion molecule-1 (sICAM-1) and soluble vascular cell adhesion molecule (sVCAM-1) [66], which may be potential biomarkers of CVD [67–69].”
Popović, D., Starčević, J. N., Letonja, M. Š., Makuc, J., Vujkovac, A. C., Pleskovič, R. Z., Gašpar, Ľ., Kružliak, P., & Petrovič, D. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0247-y · Cited by 13
“Increased concentrations of sl ICAM-1 were repored in patients with cardiovascular disease, tumors, autoimmune disease and other diseases with an inflammatory reaction [7, 12, 13].”
BackgroundSegura, M. D. C. O., Navarro, B. E. D. R., Espino, B. A. R., Marchat, L. A., Sánchez‐Muñoz, F., Villafaña, S., Hong, E., Meza‐Cuenca, F., Mailloux‐Salinas, P., Bolaños, F. J., et al. (2017) · Endocrine Research · doi:10.1080/07435800.2017.1294601 · Cited by 14
“Levels of ICAM-1 have been associated with the risk of myocardial infarction in men in the Physician’s Health Study (20,21).”
BackgroundClinical carotid atherosclerosis
Wasserman, B. A. (2002) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(02)00025-4 · Cited by 13
“Increased levels of intercellular adhesion molecule sICAM-1 have been shown to predict risk of future myocardial infarction [27].”
BackgroundCD59 or C3 are not requred for angiotensin II‐dependent hypertension or hypertrophy in mice
Coles, B., Lewis, R. D., Anning, P. B., Morton, J., Sivasankar, B., Morgan, B. P., & O’Donnell, V. B. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02598.x · Cited by 13
Patti, G., Chello, M., Pasceri, V., Colonna, D., Carminati, P., Covino, E., & Sciascio, G. D. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.09.009 · Cited by 13
Inflammation in Peritoneal Dialysis: A Latin-American Perspective
Cueto-Manzano, A. M., González–Espinoza, L., Martín-del-Campo, F., Fortes, P. C. N., & Pecoits‐Filho, R. (2007) · Peritoneal Dialysis International · doi:10.1177/089686080702700326 · Cited by 13
“In addition, prospective data strongly suggest that endothelial activation through inflammation occurs early in the atherosclerotic process and that high serum levels of inflammation markers, chemokines and adhesion molecules are predictors of future CV events in the general (5) and CKD (6) populations.”
BackgroundNitric Oxide, Atherosclerosis and the Clinical Relevance of Endothelial Dysfunction
Anderson, T. J. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-7960-5_5 · Cited by 13
Mateos‐Cáreres, P. J., García‐Méndez, A., Farré, J., de Miguel, L. S., Gómez, J., de Andrés, R., Rico, L., Romero, J., & López-Farré, A. J. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01082.x · Cited by 13
McSorley, P., Young, I. S., McEneny, J., Fee, H. J. P., & McCance, D. R. (2004) · Metabolism · doi:10.1016/j.metabol.2003.11.026 · Cited by 13
Markers of the Acute Phase Response in Cardiovascular Disease: An Update
Whicher, J. T., Rifai, N., & Biasucci, L. M. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.171 · Cited by 13
“Smoking is a powerful risk factor for cardiovascular disease and is associated with raised levels of CRP (75), IL-6 (35, 36) and other inflammatory markers such as soluble adhesion molecule 1 (76).”
BackgroundHemelaar, M., Kenemans, P., Schalkwijk, C., Braat, D. D. M., & van der Mooren, M. J. (2006) · Human Reproduction · doi:10.1093/humrep/del034 · Cited by 13
Unveiling the crucial role of intercellular adhesion molecule‐1 in secondary diabetic complications
Kaur, P., Dahiya, R., Nandave, M., Sharma, K., & Goyal, R. K. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4037 · Cited by 12
“49,50 Notably, a study by Song et al. found that women with diabetes had significantly higher sICAM ‐ 1 levels compared to women without diabetes.”
BackgroundNovel insights into the neuroendocrine control of inflammation: the role of GR and PARP1
Aprile-Garcia, F., Antunica-Noguerol, M., Budziñski, M. L., Liberman, A. C., & ARZT, E. S. (2013) · Endocrine Connections · doi:10.1530/ec-13-0079 · Cited by 15
Farzaneh‐Far, A., Rudd, J. H. F., & Weissberg, P. (2001) · British Medical Bulletin · doi:10.1093/bmb/59.1.55 · Cited by 12
Konstandin, M. H., Wabnitz, G. H., Aksoy, H., Kirchgessner, H., Dengler, T. J., & Samstag, Y. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.07.005 · Cited by 12
Quantitative genetic analysis of cellular adhesion molecules: The Fels Longitudinal Study
Lee, M., Czerwinski, S. A., Choh, A. C., Demerath, E. W., Sun, S. S., Chumlea, W. C., Towne, B., & Siervogel, R. M. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.05.027 · Cited by 12
“Moreover, a number of epidemiological studies have reported the importance of elevated levels of sICAM-1, sVCAM-1, sESEL and sPSEL to be predictive of future cardiovascular diseases (CVD), albeit with different degrees of predictive value [7–11].”
BackgroundSpeidl, W. S., Nikfardjam, M., Niessner, A., Jordanova, N., Zorn, G., Maurer, G., Schreiber, W., Wojta, J., & Huber, K. (2007) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e328040bf87 · Cited by 12
Sampietro, T., Bigazzi, F., Pino, B. D., Rossi, G., Chella, E., Lusso, S., Puntoni, M., Tuoni, M., & Bionda, A. (2004) · Heart · doi:10.1136/hrt.2003.017327 · Cited by 12
Kent, J. W., Mahaney, M. C., Comuzzie, A. G., Göring, H. H. H., Almasy, L. A., Dyer, T. D., Cole, S. A., MacCluer, J. W., & Blangero, J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.10.005 · Cited by 12
“Elevated circulating levels of the soluble form (sICAM-1) is an indicator of the proinflammatory state [2].”
BackgroundIntracellular Adhesion Molecule Concentrations in Women Who Smoke During Pregnancy
Lain, K. Y., Luppi, P., McGonigal, S. C., Roberts, J. M., & DeLoia, J. A. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000198628.43211.fc · Cited by 12
Berrahmoune, H., Herbeth, B., Lamont, J. V., Lambert, D., Blankenberg, S., Tiret, L., FitzGerald, P. S., Siest, G., & Visvikis‐Siest, S. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.279 · Cited by 12
The acute phase response in chronic haemodialysis patients: a marker of cardiovascular disease?
Nubé, M. J. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_3.19 · Cited by 12
Reilly, M. P., Wolfe, M. L., Dykhouse, J., Reddy, K., Localio, A. R., & Rader, D. J. (2004) · Journal of Investigative Medicine · doi:10.1177/108155890405200823 · Cited by 12
Adhesion Molecules and Atherosclerosis
Wang, H., & Huo, Y. (2010) · Atherosclerosis · doi:10.1002/9783527629589.ch3 · Cited by 12
Hyperhomocysteinemia and transplant coronary artery disease in cardiac transplant recipients
Miner, S. E. S., Cole, D. E. C., Evrovski, J., Verma, A., Daly, P. A., & Ross, H. J. (2001) · Clinical Transplantation · doi:10.1034/j.1399-0012.2001.150407.x · Cited by 12
Fasano, S., Iudici, M., Coscia, M. A., Messiniti, V., Borgia, A., Tirri, R., & Ciccia, F. (2022) · Lupus Science & Medicine · doi:10.1136/lupus-2022-000681 · Cited by 11
Haddad, F., Sever, M., Poglajen, G., Ležaić, L., Yang, P. C., Maecker, H. T., Davis, M. M., Kuznetsova, T., Wu, J. C., & Vrtovec, B. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.03.011 · Cited by 11
Çalan, M., Çalan, Ö. G., Gönen, M. S., Bilgir, F., Kebapçılar, L., Kulaç, E., Cinali, T., & Bilgir, O. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.4297 · Cited by 11
“1530 man tissues have shown that these CAMs are expressed at increased levels in atherosclerotic plaques (1-3).”
BackgroundAntithrombotic Drug Therapy in Cardiovascular Disease
Askari, A. T., & Lincoff, A. M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-235-3 · Cited by 11
Fragoso, J. M., Ramírez‐Bello, J., Cruz‐Robles, D., Pérez-Méndez, O. A., de la Peña-Dı́az, A., & Vargas‐Alarcón, G. (2009) · PubMed · Cited by 11
Effects of dydrogesterone on the vascular system
Seeger, H., & Mueck, A. O. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701584998 · Cited by 11
“Recent investigations showed that soluble forms of adhesion molecules can be measured in the serum [19].”
BackgroundExpanded Network of Inflammatory Markers of Atherogenesis: Where Are We Now?
Abbasi, S. H., & Boroumand, M. A. (2010) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004010038 · Cited by 11
Zee, R. Y. L., Cheng, S., Erlich, H. A., Lindpaintner, K., Rifai, N., Buring, J. E., & Ridker, P. M. (2007) · Stroke · doi:10.1161/strokeaha.107.490219 · Cited by 11
Circulating adhesion molecules are correlated with ultrasonic assessment of carotid plaques
Hashimoto, H., Kitagawa, K., Kuwabara, K., Hougaku, H., Ohtsuki, T., Matsumoto, M., & Hori, M. (2003) · Clinical Science · doi:10.1042/cs20020290 · Cited by 11
Inflammatory biomarkers of the patient with myocardial insufficiency
Blake, G. J. (2003) · Current Opinion in Critical Care · doi:10.1097/00075198-200310000-00006 · Cited by 11
Cardiopulmonary Consequences of Particle Inhalation
Frampton, M. W., Utell, M. J., & Samet, J. M. (2000) · Lung biology in health and disease · doi:10.1201/b14423-25 · Cited by 10
Circulating ICAM-1 in peripheral arterial disease as a predictor of adverse events
Blann, A. D., & McCollum, C. N. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79421-6 · Cited by 11
Wiklund, O., Hulthe, J., Bondjers, G., & Hurt‐Camejo, E. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00827.x · Cited by 11
Cytokines and adhesive molecules in detection of endothelial dysfunction.
Mizia‐Stec, K. (2006) · PubMed · Cited by 10
Moléculas solubles de adhesión intercelular tipo 1 y proteína C reactiva tras cirugía bariátrica
Soler, I. O., Gómez, F. I., Ortega, M. G., Tafalla, M. S. A., Paredes, M. P., Almela, M. L. L., Saura, M. H. P., & Díaz, M. P. (2010) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2010.01.008 · Cited by 10
Geographic Variation in Cardiovascular Inflammation among Healthy Women in the Women's Health Study
Clark, C. R., Coull, B. A., Berkman, L. F., Buring, J. E., & Ridker, P. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027468 · Cited by 10
“Elevated plasma levels of several inflammatory biomarkers including high sensitivity Creactive protein (hsCRP), soluble intercellular adhesion molecule type 1 (sICAM-1), and fibrinogen have been consistently found to predict future CVD events – including strokes and heart attacks – in healthy populations, particularly…”
BackgroundNuraeni, A., Mirwanti, R., & Anna, A. (2018) · Belitung Nursing Journal · doi:10.33546/bnj.231 · Cited by 10
Psychoneuroimmunological Pathways Involved in Acute Coronary Syndromes
Kop, W. J., & COHEN, N. (2007) · Elsevier eBooks · doi:10.1016/b978-012088576-3/50051-4 · Cited by 10
Sandford, A. J., Ha, A., Ngan, D. A., Akhabir, L., Saferali, A., Fox, N., Allen, A. J. H., Warby, S. C., van Eeden, S. F., & Ayas, N. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210732 · Cited by 10
Schratzberger, P., Kiechl, S. J., Dunzendorfer, S., Kähler, C. M., Patsch, J. R., Willeit, J., & Wiedermann, C. J. (2000) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/204748730000700407 · Cited by 10
Potential Role of Inflammation and Infection
Shah, P. K. (1999) · Cited by 10
Early use of statins in acute coronary syndromes
Spin, J. M., & Vagelos, R. H. (2003) · Current Atherosclerosis Reports · doi:10.1007/s11883-003-0068-0 · Cited by 10
“Plasma levels of inflammatory markers, such as soluble intercellular adhesion molecule-1, C-reactive protein (CRP), and interleukin-6 (IL-6), have been shown to reflect the risk of coronary events [ 15 ,16].”
BackgroundSethi, A., Misra, A., Pandey, R. M., Luthra, K., Devi, J. R., Sharma, R., Khanna, N., Dwivedi, M., & Vikram, N. K. (2002) · Disease Markers · doi:10.1155/2002/843537 · Cited by 10
Karhunen, V., Gill, D., Malik, R., Ponsford, M., Ahola‐Olli, A., Papadopoulou, A., Palaniswamy, S., Mutt, S. J., Sebert, S. P., Männikkö, M., et al. (2020) · medRxiv · doi:10.1101/2020.10.26.20219477 · Cited by 10
Li, M., Wang, J., Wang, X., & Li, G. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8275 · Cited by 9
“SICAM-1 is an intercellular adhesion molecule, which can mediate leukocyte adhesion and aggregation, and can be used as a corresponding indicator in various diseases caused by atherosclerosis (9,10).”
BackgroundDiabetic Endothelial Cell Glycogen Synthase Kinase 3β Activation Induces VCAM1 Ectodomain Shedding
Brishti, M. A., Raghavan, S., Lamar, K., Singh, U. P., Collier, D. M., & Leo, M. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814105 · Cited by 8
Enkhmaa, B., Anuurad, E., Zhang, W., Kim, K., & Berglund, L. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.02.023 · Cited by 9
Vaverková, H., Karásek, D., Novotný, D., Kovarova, D., Halenka, M., Slavík, L., & Frohlich, J. J. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.02.014 · Cited by 9
“While sVCAM-1 is a predictive marker of increased risk for future coronary events only in patients with the presence of atherosclerosis [52], sICAM-1 is predictive – like hsCRP – also in initially healthy people [53].”
BackgroundTsalamandris, S., Oikonomou, E. K., Παπαγεωργίου, Ν., & Tousoulis, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-811908-2.00005-2 · Cited by 9
Biomaterials for Stem Cell Therapy for Cardiac Disease
Kim, H., Kim, S. L., Choi, Y.-H., Ahn, Y.-H., & Hwang, N. S.-Y. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0445-3_11 · Cited by 9
Haas, M. J., Jurado-Flores, M., Hammoud, R., Feng, V., Gonzales, K., Onstead‐Haas, L., & Mooradian, A. D. (2019) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000520 · Cited by 9
Lv, Q., Sun, H., Du, Z., Jiao, X., Yu, H., Sun, Q., Fan, L., Wang, Y., Li, L., Hu, C., et al. (2021) · Sleep Medicine · doi:10.1016/j.sleep.2021.07.002 · Cited by 9
Azzopardi, D., Haswell, L. E., Frosina, J., McEwan, M., Gale, N., Thissen, J., Meichanetzidis, F., & Hardie, G. (2022) · JMIR Research Protocols · doi:10.2196/39785 · Cited by 10
“The BoPHs 11-dTX B2 [31-33], 8-epi-PGF2α type III [34,35], CIMT [36-38], COHb [39-41], FeNO [35,42], FEV1%pred [43], HDL [44-46], sICAM-1 [47-49], and WBC count [50-53] were selected to cover a range of associated smoking-related diseases, including lung cancer, cardiovascular disease, and chronic obstructive pulmonar…”
BackgroundWitsch, J., Roh, D. J., Oh, S. E., Iadecola, C., Diaz-Arrastia, R. R., Kasner, S. E., Mayer, S. A., & Murthy, S. B. (2023) · Stroke · doi:10.1161/strokeaha.123.042466 · Cited by 9
Influence of Race, Gender, Age, and Diabetes on the Skin Circulation
PETROFSKY, J. S., & Bains, G. S. (2009) · Springer eBooks · doi:10.1007/978-3-540-89656-2_61 · Cited by 9
Conen, D., Everett, B. M., Glynn, R. J., & Ridker, P. M. (2007) · Heart · doi:10.1136/hrt.2007.126169 · Cited by 9
Circulating adhesion molecules and arterial stiffness : cardiovascular topic
Kilic, I. D., Fιndıkoğlu, G., Alihanoğlu, Y. İ., Yıldız, B. S., Uslu, S., Rota, S., & Evrengul, H. (2015) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2014-060 · Cited by 9
“reported a significant association between increasing concentrations of sICAM-1 and the risk of future myocardial infarction, especially among participants with baseline sICAM-1 concentrations in the highest quartile.(12) Blankenberg et al.”
BackgroundScreening for atherosclerosis in patients with rheumatoid arthritis
Doornum, S. V., McColl, G., Jenkins, A. J., Green, D., & Wicks, I. P. (2003) · Minerva Access (University of Melbourne) · Cited by 9
The impact of OSA and CPAP treatment on cell adhesion molecules’ night-morning variation
Nikitidou, O., Daskalopoulou, E., Papagianni, A. A., Vlachogiannis, E., Dombros, N., & Liakopoulos, V. (2020) · Sleep And Breathing · doi:10.1007/s11325-020-02232-9 · Cited by 9
The Rationale for Intervention to Reduce the Risk of Coronary Heart Disease
Rippe, J., Angelopoulos, T., & Zukley, L. (2007) · American Journal of Lifestyle Medicine · doi:10.1177/1559827606292859 · Cited by 11
Metadata
- Authors
- Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J., & Allen, J.
- Affiliations
- Brigham and Women's Hospital (US)
- R&D Systems (United States) (US)
- Corresponding author
- Ridker, Paul M
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1998-01
- Volume
- 351
- Issue
- 9096
- Pages
- 88-92
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2138809584
- Cited by
- 1,229
- References
- 35
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 8 · 2023: 10 · 2022: 16 · 2021: 16 · 2020: 17 · 2019: 23 · 2018: 14 · 2017: 28 · 2016: 27 · 2015: 25 · 2014: 38 · 2013: 27 · 2012: 36
- FWCI
- 26.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- soluble intercellular adhesion molecule-1, sICAM-1, myocardial infarction, atherosclerosis, inflammation, endothelial cell adhesion, anti-adhesion therapy, cardiovascular risk, fibrinogen, homocysteine, tissue plasminogen activator, C-reactive protein, healthy men, Physicians' Health Study
- MeSH terms
- Antioxidants, Arteriosclerosis, Aspirin, Double-Blind Method, Humans, Male, Middle Aged, Myocardial Infarction, Platelet Aggregation Inhibitors, Prospective Studies, Risk Factors, Multivariate Analysis, Case-Control Studies, Intercellular Adhesion Molecule-1, beta Carotene
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review